Anti-Tubercular Glycolipids from the leaves of Sterculia setigera, Del

Slides:



Advertisements
Similar presentations
The TB Alliance-Bayer Moxifloxacin Deal
Advertisements

Treatment of infectious diseases. Drugs used in the treatment of bacterial diseases can be grouped into categories based on their modes of action: 1.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Wellcome Trust Research Career Development Fellowship: A personal perspective Samantha Sampson Department of Microbiology Centre for Molecular Microbiology.
Use of Chromatography Techniques to Identify and Isolate Chemical Substances from algae Dictyota pulchella plant. Raquel Bezerra(UFPB)Camila Figueiredo.
The University of Arizona
Introduction CAS-Croucher Funding Scheme for Joint Laboratories CAS-CF03/04.SC01 CAS-CF03/04.SC01 Isolation and purification of marine bioactive compounds.
Disease Prevention Tuberculosis.
The potential of plants as a source of anti-malarial agents Dr Geoffrey M. Rukunga Kenya Medical Research Institute PO BOX NAIROBI .
Stages of drug development
Isolating and Purifying Novel Antibiotics from Soil Bacteria Heather Fisher, Department of Biological Sciences, York College of Pennsylvania Introduction.
Introduction Microtropis fokienensis Dunn 1) (Celastraceae) is a small shrub that grows in high altitude forests throughout southern China and Taiwan.
Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus Chloe Jones Loyola Marymount University BIOL368:
CENTRE FOR BIOTECHNOLOGY
COLUMN CHROMATOGRAPHY
Tuberculosis Case Study Presenter Xoliswa Poswa TB Laboratory, NHLS/CMID.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
Tuberculosis is a global public health issue. The Role of the International Agencies Introduction TB which stands for Tuberculosis is a rather infectious.
Neuroactive Compounds From Mollusk-Associated Bacteria Zhenjian Lin 1, Ma. Diarey B. Tianero 1,2, Rowena Antemano 1,2, Olivier Peraud 1, Margo Haygood.
Abstract Modern chemotherapy has played a major role in our control of tuberculosis. Yet tuberculosis still remains a leading infectious disease worldwide.
Tuberculosis. Tuberculosis is an infectious disease caused by the organism Mycobacterium tuberculosis. Unlike most other bacteria, M. Tuberculosis is.
J. Nat. Prod. 2004, 67, New Nardosinanes and 19-Oxygenated Ergosterols from the Soft Coral Nephthea armata Collected in Taiwan Ali A. H. El-Gamal,
Towards an Integrated Research Policy in the Area of Drug Discovery in the Arab Countries Including mechanisms to better utilization of their terrestrial.
PROTEASOME INHIBITION AND NOT NF-ΚB INHIBITION INDUCES APOPTOSIS TO RESISTANT CELLS IN GLUCOCORTICOID-INDUCED APOPTOSIS George I Lambrou 1, Apostolos Zaravinos.
Treatment of Infectious Diseases. ›Drugs used to treat bacterial diseases are grouped into categories based on their modes of action Treatment of Bacterial.
The death of a disease TB(tuberculosis).
MYCOBACTERIA Dr.Qurat-Ul-Ain Senior Demonstrator Microbiology, KEMU, Lahore.
Depart. of Pulmonology 백승숙. More than 80% of cases of tuberculosis in the United States –The result of reactivated latent infection –Nearly all these.
Important diseases and their global impact Objectives To be able to describe the causes and means of transmission of malaria, AIDS/HIV and T.B To be able.
Professor Stephen Pyne School of Chemistry, University of Wollongong, New South Wales 2522, Australia  Research within the Pyne group.
Phytochemical investigations of two South African plants 26 June 2007 Presentation by Eric Khorombi Researcher CSIR Biosciences Bioprospecting platform.
SYNTHESIS OF CHOLANE AND LANOSTANE DERIVATIVES
INTRODUCTION Most pathogenic bacteria becoming resistant to drugs, due to indiscriminate use of antibiotics . It becomes a greater problem of giving treatment.
Tuberculosis.
PHYTOCHEMICAL INVESTIGATION RESULTS AND DISCUSSION
HEALTH PROMOTION.
Fatima mohammed Abedalwahab An-Najah National University
The New Penicillin?: Antimicrobial Effects of Puupehenone on Clostridium Difficile Nikki Huynh, Dr. William T. Self Ph.D. Department of Molecular Biology.
Results and discussion
Secretion of cAMP in Mycobacterium Under Various Conditions
Figure 5. Treatment of the checkpoint inhibitor related toxicity
Plant Material (Air dried and crushed)
1. Abstract 3. Objective of the study 4. Methods 5. Results
Low Level of Pre-Vaccination Measles Antibody among Infants Receiving Measles Immunization In Ilorin,
Investigating the role of Ca+2/calmodulin dependent kinase pathways
Efficacy Study Of Potential Anti-tubercular Molecules:
Mycobacterium tuberculosis Characteristics
Molecular study of two types of mutations in promoters of IL-2 and IL-10 genes in Iraqi patients with Tuberculosis Mazin S.Salman Awatif.
Three lessons I learned
Isolation and purification of marine bioactive compounds
Hypoglycaemic potential of Tapinanthus bangwensis
UNIT 2.3 METHODS IN NATURAL PRODUCTS CHEMISTRY
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Envisaged Flow Synthesis of (1)
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
2. Chemistry Department, Faculty of Science, Cairo University.
Drug Resistance and the Three Great Pandemics
Envisaged Flow Synthesis of 1
Investigate the Treatment of Infectious Diseases
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Investigate the Treatment of Infectious Diseases
BCG Vaccination Dr Lika Nehaul CCDC / NPHS TB Programme Lead
Tuberculosis.
Abebe Genetu Bayih, PhD University of Gondar
Symposium, Edo State Polytechnic, Usen
Discussion and Future Work
Presentation transcript:

Anti-Tubercular Glycolipids from the leaves of Sterculia setigera, Del Anti-Tubercular Glycolipids from the leaves of Sterculia setigera, Del .(Sterculiaceae) Ibrahim T. Babalola1,2, Esther A. Adelakun2* and Scott G.Franzblau3 1. Dept. of Chemistry, Faculty of Natural Sciences, Yobe State University, PMB 1144 Damaturu, Nigeria, chemibrabal@gmail.com, +234(0)8035879874 2. Dept. of Chemistry, Faculty of Natural Sciences, University of Jos, Jos, Nigeria , Debola2000@yahoo.com, +234(0)8037032496 3. Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833South Wood Street Chicago, IL 60612, United States UNIJOS 40th Celebration – Book Fair/Research Exhibition, 2015. Introduction Aims & Objectives The goal of this study is to identify phytochemicals that posses in vitro cidal effect or potent inhibitory activity against Mycobacterium tuberculosis in the study plant. A long term goal of this research is to identify novel natural products that have the potential of becoming new drug leads for anti-Tb drug development. Fractionation Tree on Sterculia setigera Leaves Pulverized dried leaves (0.7 kg) Percolation Hexane, DCM, &EtoAc extracts combined. 40.0g on silica gel NP VLC eluted with a gradient of Hexane-EtOAc-MeOH (5% stepwise increase) 40 fractions combined based on activity distribution Fr(1-6) E1.1 Fr(7-12) E1.2 Fr(13-16) E1.3 Fr(17) E1.4 Fr(18-23) E1.5 Fr(1-4) A Fr(5-7) B Fr(8-12) C Fr(13-23) D Fr(28-40) F NP VLC, eluted with a gradient of Hex-EtOAc-MeOH (10% stepwise increase) to afford 23 fractions. MIC=128ug/ml MIC=55.52ug/ml MIC=28.65ug/ml MIC=54.84ug/ml MIC=63.01ug/ml Fr(60%) E.1.3.2 Fr(50%) E.1.3 Fr(70%) E1.3.3 Fr(80%) E1.3.4 Fr(85%) E1.3.5 Fr (90%) E.1.3.6 Fr (98%) E.1.3.7 RP C18, gradient of MeOH-Water(50%,60%,70%,80%,90%,98%) at 1.6ml/min. 300mg RP MPLC Historically tuberculosis (TB) is one of the oldest and most pervasive diseases in history. Worldwide, TB is caused by Mycobacterium tuberculosis (MTB) and to a lesser degree M. bovis and M. africanum, and continues to be a major disease of global importance (Okunade et al .,2004). Mycobacterium tuberculosis, the bacterium that causes this disease, is protected from the host by a unique cell wall. It is a highly infective airborne and chronic disease usually infecting the lungs, although other organs are also involved. Although the number of tuberculosis (TB)-related deaths appears to have stabilized at around 2million per annum, the incidence of new infections is rising, largely owing to the HIV epidemic (Gutierrez-Lugo and Bewley , 2008). There are many challenges to eradicating TB, not least of which are the complexity associated with the disease, such as latency and drug resistance (Gutierrez-Lugo and Bewley , 2008). Methodology The Pulverized leaves of Sterculia Setigera was extracted using percolation method. The anti-TB activity of the leaves extract was investigated by bioactivity-guided fractionation against virulent strains of Mycobacterium tuberculosis (H37Rv (ATCC27294)) in vitro, using the Alamar Blue Assay (MABA). The method has the advantage of being simple and do not require radioactive substrates and less risk of contamination as it is carried out in a containment lab (Collins and Franzblau,1997). Repeated purifications of the active fractions using combination of normal and reverse phase chromatography led to the isolation of a pure fraction with an interesting anti-TB activity. Fr(24-27) E 1000mg loaded dry on to silica gel Proposed Structure of the major Glycolipids (2S)-1-O-(monodecane)-glyceryl-β-D-galactopyranoside) E1.3.4 E1.3.5 Gradient of MeOH-Water (75%,77%.80%.85%,90% &98% 306 fractions generated, like fractions combined.1.0 mg each sampled for anti-TB assay 160 mg On RP C18 RP MPLC Fraction 7&8 NP VLC ,Silica gel, eluted with a gradient solvent system of hexane - Eto Ac-TFA(5:5:0.1-2:8:0.1) cv Fr E1.3.4&5. (12+13). (11-14) coded Ibe_13 Wt = 0.41 mg Fr E1.3.4&5. (12+13). (15-17) coded IBe_14 Wt= 0.48mg Conclusion Natural products continue to play a most significant role in the drug discovery and development process (Newman and Cragg, 2007), and plants are recognised as useful source of highly active antimycobacterial metabolites(Gibbons, 2005). Repeated purifications of the active fractions from S. setigera extract using combination of normal and reverse phase chromatography led to the isolation of a pure fraction with an interesting anti-TB activity (100 % inhibition against the virulent strain of Mycobacterium tuberculosis, MICof 15.13 µg/ml). The cytotoxicity of this compound was also evaluated against African green monkey kidney cells (Vero cells) and human hepatocellular carcinoma (HepG2) cell lines and were found non-toxic to both cell lines (IC50 102.4, 81.08 µg/ml respectively). Spectroscopic studies shows that the most active fraction is a mixture of two isomeric glycolipids (1H, 13C nmr). The major component of the mixture is proposed to be ((2S)-1-O-(monodecane)-glyceryl-β-D-galactospyranoside) by simulation using ChemDraw software. Effort is ongoing to separate the mixture for complete individual structure elucidation. This report confirms the anti-TB activity of Sterculia setigera as claimed in ethnomedicine and establish the fact that the anti-tubercular agents in S. setigera leaves are glycolipids . This is the first report on the occurrence of biologically active glycolipids from S. setigera leaves. The Global Challenge The drug used in the present day six-month combination therapy for treating tuberculosis were discovered 40 years ago. New drugs for tuberculosis are urgently needed to shorten the duration of therapy and to effectively treat drug-resistant TB and to eliminate the latent state. Such new anti-mycobacterium compound must posses suitable pharmacological targets that could affect cell wall synthesis, bacterial survival and be able to inhibit the mechanism by which these organisms overcome the early immune response of the host (Mc Kinney et al.,2000). The WHO estimates that if efforts do not change, by 2020, nearly 1 billion additional people will be newly infected with tuberculosis, 200 million people will become sick, and 35 million will die of the disease. (WHO, 2002) MIC=>128, MIC=>128 , MIC=>128, MIC=>128, MIC=38.9, MIC=53.2, MIC=15.1, MIC=29.7, MIC=63.7, MIC=118, MIC=>128, MIC=>128, MIC=>128, MIC=>128, MIC=31.4, MIC=>128, MIC=>128 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Results of Anti-TB Assay of sub-fractions E1.3.4&5 of Sterculia setigera Fraction Code Percentage Inhibition at Tested Concentrations MIC µg/ml IC50 Vero HepG2 8 µg/ml 16 µg/ml 32 µg/ml 64 µg/ml 128 µg/ml E1.3.4&5.1 -6 6 54 >128 NT E1.3.4&5.2 -21 7 8 61 E1.3.4&5.3 -14 -15 25 65 55 E1.3.4&5.4 -1 -7 37 45 72 E1.3.4&5.5 2 87 99 38.99 101.2 E1.3.4&5.6 -3 9 71 100 53.21 87.21 44.1 E1.3.4&5.7 20 98 15.13 102.4 81.08 E1.3.4&5.8 15 32 29.68 99.35 81.69 E1.3.4&5.9 -11 -22 22 91 63.66 108.2 80.71 E1.3.4&5.10 -5 -16 29 118.27 35.46 24.56 E1.3.4&5.11 -29 27 33 E1.3.4&5.12 -50 13 E1.3.4&5.13 -24 14 18 E1.3.4&5.14 -25 23 10 17 E1.3.4&5.15 1 36 24 E1.3.4&5.16 60 93 31.43 25.44 30.22 E1.3.4&5.17 41 70 86 90 128.00 31.75 28.44 E1.3.4&5.18 -10 28 44 RMP 95 0.05 185.3 97.85 Antimycobacterial Natural Products Natural products form one avenue in the search for new antitubercular agents with many groups undertaken screening of natural products from higher plants, fungi and marine organisms as the preliminary step to finding new lead compounds (Okunade et al., 2004, Copp, 2003). Naturally occurring compounds from higher plants, fungi and marine organisms that demostrated significant inhibitory activity in the in vitro bioassays against mycobacterium tuberculosis and other mycobacterial species have been reported (Copp, 2003, Newton et al., 2000). Acknowledgements Institute for Tuberculosis Research, University of Illinois at Chicago, USA. Natural Products Group, Department of Pharmacy and Pharmacognosy, University of Illinois at Chicago, USA. Tertiary Education Fund (TETFund), Abuja, Nigeria. It calls for celebration! Its time to celebrate!! Our Alma Mater is 40 !!! Strain: H37Rv; Stock conc.:12.8 mg/ml; Test conc.:128-8 µg/ml ; NT- Not tested. Order online at https://www.postersession.com/order/